Justyna Rybka

2.3k total citations · 1 hit paper
71 papers, 1.1k citations indexed

About

Justyna Rybka is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Justyna Rybka has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 22 papers in Hematology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Justyna Rybka's work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (14 papers). Justyna Rybka is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (14 papers). Justyna Rybka collaborates with scholars based in Poland, United States and Sweden. Justyna Rybka's co-authors include Tomasz Wróbel, Katarzyna Wicherska‐Pawłowska, Kazimierz Kuliczkowski, Grzegorz Mazur, Aleksandra Butrym, Dagmara Baczyńska, Rafał Poręba, Bożena Jaźwiec, Andrzej Tukiendorf and Katarzyna Bogunia‐Kubik and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Justyna Rybka

62 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases

2021 227 citations Katarzyna Wicherska‐Pawłowska, Tomasz Wróbel et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Justyna Rybka Poland	17	391	298	159	145	135	71	1.1k
Ghasem Solgi Iran	20	291 0.7×	392 1.3×	112 0.7×	162 1.1×	128 0.9×	93	1.3k
Akira Shiraishi Japan	16	364 0.9×	414 1.4×	157 1.0×	263 1.8×	88 0.7×	38	1.0k
Sonya Abraham United Kingdom	15	484 1.2×	599 2.0×	166 1.0×	263 1.8×	140 1.0×	44	1.5k
Yu Si China	21	385 1.0×	334 1.1×	121 0.8×	183 1.3×	52 0.4×	81	1.1k
Kazuyuki Matsuda Japan	22	498 1.3×	425 1.4×	141 0.9×	359 2.5×	370 2.7×	114	1.6k
Yuji Nakamachi Japan	16	553 1.4×	154 0.5×	349 2.2×	104 0.7×	153 1.1×	49	1.1k
Jong‐Baeck Lim South Korea	23	415 1.1×	488 1.6×	144 0.9×	320 2.2×	36 0.3×	62	1.5k
Sarah McKenna United States	14	529 1.4×	562 1.9×	121 0.8×	382 2.6×	217 1.6×	36	1.6k
Piotr Tymoszuk Austria	22	425 1.1×	403 1.4×	129 0.8×	287 2.0×	366 2.7×	60	1.5k

Countries citing papers authored by Justyna Rybka

Since Specialization

Citations

This map shows the geographic impact of Justyna Rybka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justyna Rybka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justyna Rybka more than expected).

Fields of papers citing papers by Justyna Rybka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justyna Rybka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justyna Rybka. The network helps show where Justyna Rybka may publish in the future.

Co-authorship network of co-authors of Justyna Rybka

This figure shows the co-authorship network connecting the top 25 collaborators of Justyna Rybka. A scholar is included among the top collaborators of Justyna Rybka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justyna Rybka. Justyna Rybka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bogusławska, Dżamila M., et al.. (2025). Two Variants of the ANK1 Gene Associated with Hereditary Spherocytosis. Biomedicines. 13(2). 308–308.

Łacina, Piotr, et al.. (2025). Evaluation of polymorphism in BCL-2, PD-1, and PD-L1 genes in myelodysplastic neoplasms. Acta Haematologica Polonica. 56(3). 222–230. 1 indexed citations

Wróbel, Tomasz, et al.. (2023). The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes. International Journal of Molecular Sciences. 24(5). 4708–4708. 6 indexed citations

Drozd‐Sokołowska, Joanna, Ewa Paszkiewicz‐Kozik, Marta Morawska, et al.. (2023). Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group. Annals of Hematology. 102(8). 2119–2126. 4 indexed citations

Wicherska‐Pawłowska, Katarzyna, Katarzyna Bogunia‐Kubik, Piotr Łacina, et al.. (2022). Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia. International Journal of Molecular Sciences. 23(17). 9593–9593. 3 indexed citations

Kalicińska, Elżbieta, Barbara Adamik, Danuta Nowicka‐Suszko, et al.. (2021). Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study. Cells. 10(6). 1293–1293. 20 indexed citations

Kalicińska, Elżbieta, Monika Biernat, Justyna Rybka, et al.. (2021). Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study. Journal of Clinical Medicine. 10(19). 4373–4373. 21 indexed citations

Rybka, Justyna & Tomasz Wróbel. (2021). Treatment of Hodgkin lymphoma relapse after autologous hematopoietic cell transplantation. Acta Haematologica Polonica. 52(4). 309–313.

Kalicińska, Elżbieta, et al.. (2020). Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study. Translational Oncology. 14(1). 100943–100943. 12 indexed citations

10.

Czyż, Anna, et al.. (2020). Higher efficacy of intermediate dose cytarabine + G‐CSF compared to cyclophosphamide + G‐CSF in hematopoietic stem cell mobilization in patients with multiple myeloma. Journal of Clinical Apheresis. 35(4). 246–254. 2 indexed citations

11.

Rybka, Justyna, et al.. (2017). Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison. Clinical Lymphoma Myeloma & Leukemia. 17(5). 268–273. 3 indexed citations

12.

Butrym, Aleksandra, et al.. (2016). Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma. Archivum Immunologiae et Therapiae Experimentalis. 64(S1). 151–156. 11 indexed citations

13.

Jurczak, Wojciech, Sebastian Giebel, Maciej Machaczka, et al.. (2015). Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Medical Oncology. 32(4). 90–90. 9 indexed citations

14.

Rybka, Justyna, et al.. (2015). Azacitidine in outpatient treatment – single center experience. Współczesna Onkologia. 6(6). 467–470. 2 indexed citations

15.

Małkowski, Bogdan, Edyta Subocz, Justyna Rybka, et al.. (2014). Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Leukemia & lymphoma. 56(2). 377–382. 17 indexed citations

16.

Wróbel, Tomasz, Grzegorz Mazur, Justyna Rybka, et al.. (2013). VEGF and bFGF gene polymorphisms in Polish patients with B-CLL. Medical Oncology. 30(1). 456–456. 7 indexed citations

17.

Butrym, Aleksandra, Mirosław Majewski, Justyna Rybka, Kazimierz Kuliczkowski, & Grzegorz Mazur. (2012). High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients. Leukemia Research. 36(7). 876–880. 14 indexed citations

18.

Wróbel, Tomasz, et al.. (2011). Primary pulmonary diffuse large B‐cell lymphoma. American Journal of Hematology. 87(1). 107–108. 17 indexed citations

19.

Rybka, Justyna, Tomasz Wróbel, Bożena Jaźwiec, et al.. (2011). Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias. Leukemia & lymphoma. 52(12). 2336–2341. 2 indexed citations

20.

Rybka, Justyna, Tomasz Wróbel, Grzegorz Mazur, et al.. (2009). Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin’s lymphoma. Medical Oncology. 27(3). 743–746. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact